You searched for "gases"
Ophthalmic mentors: In conversation with Professor Harminder Dua
In the first of a series of interviews with key figures in the world of ophthalmology, Eye News speaks to Professor Harminder Dua about the future of clinical academia, his recent College presidency and Dua’s Layer. Professor Harminder Dua is...Shared vision: Father and son navigate life with glaucoma together
Glaucoma UK is a charity dedicated to supporting people living with glaucoma across the UK. They’re getting ready for Glaucoma Awareness Week, an annual awareness raising campaign, which is running from 24–30 June.In conversation with Marc Labetoulle
Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...Winner Announcement - Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.The past and the future for paediatric ophthalmology
The past 25 years have seen remarkable advances in clinical eye care for children in the UK. This has led to both improved outcomes and better patient and family experiences. There have been substantial changes to patient pathways, major advances...In conversation with Christopher Liu OBE
Eye News caught up with Christopher Liu following his recent appointment by Her Majesty Queen Elizabeth II as an Officer of the Most Excellent Order of the British Empire for Services to Ophthalmology. Christopher Liu OBE. Congratulations on your recent...
Post hoc analysis of the CANTREAT randomised trial
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...Applying for ophthalmology ST1 in 2026: What’s new?
Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...Could the sclera be key to glaucoma?
The glaucomas are a group of conditions characterised by optic neuropathy and associated visual field defects. Of these, chronic open-angle glaucoma (COAG) – diagnosed on the basis of progressive structural changes to the optic nerve head (ONH) and nerve fibre...Edinburgh local plans to run Scottish half marathon for Fight for Sight
A local to Edinburgh and East Lothian who suffers from Stargardts disease will run the Scottish half marathon to fundraise for Fight for Sight.
Keratoconus: Diagnosis and Management
From the history of keratoconus to its diagnosis and management, this book covers everything. Don’t be fooled by thinking keratoconus is a simple disease like I did; this book is dense, and packed with information. The book is divided into...
